Yu HJ - Search Results

1

MRI measurements of tumor size and pharmacokinetic parameters as early predictors of response in breast cancer patients undergoing neoadjuvant anthracycline chemotherapy.

Yu HJ, Chen JH, Mehta RS, Nalcioglu O, Su MY. Yu HJ, et al. J Magn Reson Imaging. 2007 Sep;26(3):615-23. doi: 10.1002/jmri.21060. J Magn Reson Imaging. 2007. PMID: 17729334

2

A longitudinal study of radiation-induced changes in tumor vasculature by contrast-enhanced magnetic resonance imaging.

Yu H, Su MY, Wang Z, Nalcioglu O. Yu H, et al. Radiat Res. 2002 Aug;158(2):152-8. doi: 10.1667/0033-7587(2002)158[0152:alsori]2.0.co;2. Radiat Res. 2002. PMID: 12105984

3

Measurement of volumetric and vascular changes with dynamic contrast enhanced MRI for cancer therapy monitoring.

Su MY, Yu H, Chiou JY, Wang J, Nalcioglu O, Fruehauf JP, Mehta RS, Baick CH. Su MY, et al. Technol Cancer Res Treat. 2002 Dec;1(6):479-88. doi: 10.1177/153303460200100608. Technol Cancer Res Treat. 2002. PMID: 12625775 Free article.

4

Congruent MRI and near-infrared spectroscopy for functional and structural imaging of tumors.

Gulsen G, Yu H, Wang J, Nalcioglu O, Merritt S, Bevilacqua F, Durkin AJ, Cuccia DJ, Lanning R, Tromberg BJ. Gulsen G, et al. Technol Cancer Res Treat. 2002 Dec;1(6):497-505. doi: 10.1177/153303460200100610. Technol Cancer Res Treat. 2002. PMID: 12625777 Free article.

5

In vivo quantification of optical contrast agent dynamics in rat tumors by use of diffuse optical spectroscopy with magnetic resonance imaging coregistration.

Cuccia DJ, Bevilacqua F, Durkin AJ, Merritt S, Tromberg BJ, Gulsen G, Yu H, Wang J, Nalcioglu O. Cuccia DJ, et al. Appl Opt. 2003 Jun 1;42(16):2940-50. doi: 10.1364/ao.42.002940. Appl Opt. 2003. PMID: 12790443

6

Coregistration of diffuse optical spectroscopy and magnetic resonance imaging in a rat tumor model.

Merritt S, Bevilacqua F, Durkin AJ, Cuccia DJ, Lanning R, Tromberg BJ, Gulsen G, Yu H, Wang J, Nalcioglu O. Merritt S, et al. Appl Opt. 2003 Jun 1;42(16):2951-9. doi: 10.1364/ao.42.002951. Appl Opt. 2003. PMID: 12790444

7

Inhibition of thrombosis in melanoma allografts in mice by endogenous mast cell heparin.

Samoszuk M, Corwin M, Yu H, Wang J, Nalcioglu O, Su MY. Samoszuk M, et al. Thromb Haemost. 2003 Aug;90(2):351-60. doi: 10.1160/TH03-02-0088. Thromb Haemost. 2003. PMID: 12888884

8

Correlation of dynamic contrast enhancement MRI parameters with microvessel density and VEGF for assessment of angiogenesis in breast cancer.

Su MY, Cheung YC, Fruehauf JP, Yu H, Nalcioglu O, Mechetner E, Kyshtoobayeva A, Chen SC, Hsueh S, McLaren CE, Wan YL. Su MY, et al. J Magn Reson Imaging. 2003 Oct;18(4):467-77. doi: 10.1002/jmri.10380. J Magn Reson Imaging. 2003. PMID: 14508784

9

Serial MRI after experimental febrile seizures: altered T2 signal without neuronal death.

Dubé C, Yu H, Nalcioglu O, Baram TZ. Dubé C, et al. Ann Neurol. 2004 Nov;56(5):709-14. doi: 10.1002/ana.20266. Ann Neurol. 2004. PMID: 15389889 Free PMC article.

10

Pharmacokinetic parameters analyzed from mr contrast enhancement kinetics of multiple malignant and benign breast lesions detected in the same patients.

Su MY, Yu HJ, Carpenter PM, McLaren CE, Nalcioglu O. Su MY, et al. Among authors: yu hj. Technol Cancer Res Treat. 2005 Jun;4(3):255-63. doi: 10.1177/153303460500400305. Technol Cancer Res Treat. 2005. PMID: 15896081 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

982 results

Search Page

Filters